This week in MathOnco 210
Cancer origins, lineage tracing, agent-based spatial models, reciprocal cell-cell interactions
“This week in Mathematical Oncology” — May 19, 2022
> mathematical-oncology.org
From the editor:
Welcome to another edition of the Mathematical Oncology newsletter. Today we feature articles on cancer origins, lineage tracing, agent-based spatial models, reciprocal cell-cell interactions, and more. Enjoy,
Jeffrey West
jeffrey.west@moffitt.org
"There is an infinite number of incorrect theories correctly explaining the finite number of experimental data."
-Niels Bohr
Attribution of cancer origins to endogenous, exogenous, and preventable mutational processes
Vincent L. Cannataro, Jeffrey D. Mandell, Jeffrey P. TownsendDynamic patterns of microRNA expression during acute myeloid leukemia state-transition
David E. Frankhouser, Denis O’Meally, Sergio Branciamore, Lisa Uechi, …, Nadia Carlesso, Guido Marcucci, Russell C. Rockne, Ya-Huei KuoLineage tracing reveals the phylodynamics, plasticity, and paths of tumor evolution
Dian Yang, Matthew G. Jones, Santiago Naranjo, William M. Rideout III, …, Michelle M. Chan, Nir Yosef, Tyler Jacks, Jonathan S. WeissmanInterrogating and Quantifying In Vitro Cancer Drug Pharmacodynamics via Agent-Based and Bayesian Monte Carlo Modelling
Marios Demetriades, Marko Zivanovic, Myrianthi Hadjicharalambous, Eleftherios Ioannou, …, Nevena Milivojevic, Odysseas Kokkinos, Roman Bauer, Vasileios VavourakisUsing multiple scale spatio-temporal patterns for validating spatially explicit agent-based models
Jeon-Young Kang, Jared Aldstadt
Agent-based Modeling of Tumor and Immune System Interactions in Combinational Therapy with Low-dose 5-fluorouracil and Dendritic Cell Vaccine in Melanoma B16F10
Sarah Rahbar, Sajad Shafiekhani, Armin Allahverdy, Arezoo Jamali, … Sima Habibi, Bahador Makkiabadi, Jamshid Hadjati, Amir Homayoun JafariTumor cell malignancy: A complex trait built through reciprocal interactions between tumors and tissue-body system
Jean Feunteun, Pauline Ostyn, Suzette DelalogeIntegrating mechanism-based modeling with biomedical imaging to build practical digital twins for clinical oncology
Chengyue Wu, Guillermo Lorenzo, David A. Hormuth II, Ernesto A. B. F. Lima, Kalina P. Slavkova, Julie C. DiCarlo, John Virostko, Caleb M. Phillips, Debra Patt, Caroline Chung, Thomas E. YankeelovQuantitative System Pharmacology as a Legitimate Approach to Examine Extrapolation Strategies used to Support Pediatric Drug Development
Karim Azer, Jeffrey S. Barrett
On tumoural growth and treatment under cellular dedifferentiation
Matthias M. Fischer, Nils BlüthgenTethering distinct molecular profiles of single cells by their lineage histories to investigate sources of cell state heterogeneity
Anna Minkina, Junyue Cao, Jay ShendureClonally heritable gene expression imparts a layer of diversity within cell types
Jeff E. Mold, Martin H. Weissman, Michael Ratz, Michael Hagemann-Jensen, …, Joakim Lundeberg, Rickard Sandberg, Jakob Michaëlsson, Jonas FrisénSpatial cumulant models enable spatially informed treatment strategies and analysis of local interactions in cancer systems
Sara Hamis, Panu Somervuo, J. Arvid Ågren, Dagim Shiferaw Tadele, Juha Kesseli, Jacob G. Scott, Matti Nykter, Philip Gerlee, Dmitri Finkelshtein, Otso OvaskainenPicking winners in cell-cell collisions: wetting, speed, and contact
Pedrom Zadeh, Brian A. Camley
ABM Digest
Newsletter on agent-based modeling, edited by Bill Jeffries (@billjeffries93). Subscribe here, or view the past issues of this newsletter, here.
The newsletter now has a dedicated homepage where we post the cover artwork for each issue. We encourage submissions that coincide with the release of a recent paper from your group.
(GIF may take a second to load)
Caption: “Tumor sequencing data reveal variants that have suffused throughout cancer genomes in tell-tale patterns. However, these mutational signatures do not directly represent the contribution of mutagenic processes to tumor formation, as the vast majority of variants have no role in tumorigenesis. To tie mutagenic processes to the tumor phenotype, one must determine the contribution of each variant in a tumor to increases in cellular growth and survival, and then link this quantification of cancer effect size to the likelihood each variant was fueled by each detected mutagenic process in the tumor. In a recent paper published in Molecular Biology and Evolution, Cannataro et al. made this connection in thousands of tumors of 24 cancer types. In a given tumor, the processes fueling mutation and selection are often very different. Each row in this cover image represents a different tumor type, and the different colors represent different mutational processes. The image, based off Fig. 4 in the manuscript, transitions from representing the sum of processes fueling mutation in each tumor type and the sum of the contribution of the processes to tumor phenotype, with the “phenotype” bars represented in the thumbnail.“
Created by: Vincent L. Cannataro (@VinCannataro), Jeff Townsend (@JeffTownsend)
Visit the mathematical oncology page to view jobs, meetings, and special issues. We will post new additions here, but the full list can found at mathematical-oncology.org.
1. Jobs
Current subscriber count: ~1.2k